Table 4.
Application of curcumin in vivo-animal models.
| Curcumin Form | Activity | Animal Model | Reference |
|---|---|---|---|
| Curcumin Nanocurcumin |
Antidepressive effect Wound-healing Agent |
Sprague–Dawley rats Male Wistar rats |
[126] [127] |
| Curcumin, nanoparticles | Antibacterial and anti-inflammatory agent | Male C57BL/6 mice | [128] |
| Curcumin | Inhibitors of NF-κB | Mus musculus, C57BL/6J | [129] |
| Curcumin | Decontaminate and accelerate the Wound contraction | Wistar Rats | [130] |
| Curcumin, Nanoparticles | Adjuvant agent for the treatment of Hodgkin’s Lymphoma |
Mice | [131] |
| Curcumin, Nanoparticles | Contrasting agent | Sprague–Dawley rats | [132] |
| Curcumin C3 Complex | Cancer prevention | Male C57BL/6 wild-type mice | [133] |
| Curcumin, Hydrogel | Wound-healing agent | Mus musculus var. albino mice | [134] |
| PVA/Chitosan/Curcumin Patches | Wound-healing agent | Wistar Rats | [135] |